Clifford Swan Investment Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,100
Closed -$93K 342
2021
Q3
$93K Hold
10,100
﹤0.01% 328
2021
Q2
$101K Hold
10,100
﹤0.01% 321
2021
Q1
$117K Hold
10,100
﹤0.01% 322
2020
Q4
$97K Sell
10,100
-2,900
-22% -$27.9K ﹤0.01% 318
2020
Q3
$117K Sell
13,000
-500
-4% -$4.5K 0.01% 310
2020
Q2
$166K Buy
13,500
+500
+4% +$6.15K 0.01% 296
2020
Q1
$117K Hold
13,000
0.01% 288
2019
Q4
$127K Sell
13,000
-1,820
-12% -$17.8K 0.01% 314
2019
Q3
$102K Sell
14,820
-105,863
-88% -$729K 0.01% 309
2019
Q2
$1.11M Buy
120,683
+370
+0.3% +$3.42K 0.06% 158
2019
Q1
$1.89M Sell
120,313
-7,385
-6% -$116K 0.1% 130
2018
Q4
$1.97M Sell
127,698
-4,600
-3% -$70.9K 0.12% 121
2018
Q3
$2.85M Sell
132,298
-736
-0.6% -$15.9K 0.15% 115
2018
Q2
$3.24M Sell
133,034
-3,870
-3% -$94.1K 0.18% 109
2018
Q1
$2.34M Sell
136,904
-19,610
-13% -$335K 0.13% 115
2017
Q4
$2.97M Sell
156,514
-64,780
-29% -$1.23M 0.16% 112
2017
Q3
$3.9M Sell
221,294
-8,060
-4% -$142K 0.24% 101
2017
Q2
$7.62M Buy
229,354
+56,925
+33% +$1.89M 0.48% 70
2017
Q1
$5.53M Buy
172,429
+59,575
+53% +$1.91M 0.35% 83
2016
Q4
$4.09M Buy
112,854
+57,545
+104% +$2.09M 0.27% 91
2016
Q3
$2.55M Sell
55,309
-900
-2% -$41.4K 0.17% 108
2016
Q2
$2.82M Buy
56,209
+22,200
+65% +$1.11M 0.2% 103
2016
Q1
$1.82M Buy
34,009
+500
+1% +$26.8K 0.12% 121
2015
Q4
$2.2M Buy
33,509
+50
+0.1% +$3.28K 0.15% 110
2015
Q3
$1.89M Sell
33,459
-10,415
-24% -$588K 0.14% 111
2015
Q2
$2.59M Sell
43,874
-18,100
-29% -$1.07M 0.17% 104
2015
Q1
$3.86M Hold
61,974
0.25% 86
2014
Q4
$3.56M Sell
61,974
-14,100
-19% -$811K 0.24% 89
2014
Q3
$4.09M Sell
76,074
-18,182
-19% -$977K 0.28% 81
2014
Q2
$4.94M Sell
94,256
-30,479
-24% -$1.6M 0.33% 76
2014
Q1
$6.59M Sell
124,735
-30,017
-19% -$1.59M 0.46% 62
2013
Q4
$6.2M Sell
154,752
-3,477
-2% -$139K 0.45% 63
2013
Q3
$5.98M Buy
158,229
+7,167
+5% +$271K 0.48% 64
2013
Q2
$5.92M Buy
+151,062
New +$5.92M 0.49% 61